Photo by Innerbody Research
If you're exploring alpha-lipoic acid (ALA) supplements, you're likely seeking relief from nerve discomfort, help with blood sugar issues, or support for your overall health. Recently, ALA has drawn significant attention for its potential benefits in easing diabetic neuropathy symptoms and improving metabolic health.
Your body produces ALA naturally, but only in small amounts. Supplementing with ALA in higher doses — especially at doses studied in clinical trials — may help reduce nerve pain, support insulin sensitivity, and counter oxidative stress.1 2 3 However, as with most supplements, not every ALA product on the market is equally effective or trustworthy.
In this guide, we highlight the best alpha-lipoic acid supplements based on clinical evidence, appropriate dosing, and third-party testing. We also walk through how to take ALA and other important safety considerations. Whether you're managing a specific condition or simply exploring ways to support your health, our guide can help you choose the right product.
We’ve included a quick summary of our top recommendations below. You’ll find the full breakdown and supporting research in the sections that follow.
Double Wood achieves the right dose of racemic ALA and does so at a competitive price and with third-party testing for your peace of mind.
The 600mg of racemic ALA in Double Wood’s capsule-based serving aligns most closely with what human studies demonstrate to be effective. Double Wood keeps its prices on the low side and makes third-party testing results available to all. And the ability to divide the daily dose into two 300mg servings helps those with gastrointestinal sensitivity. You can find it via Double Wood’s website as well as Amazon, but we’d recommend buying from its Amazon store at this time for cost reasons. The per-bottle cost via Amazon is even less expensive.
Over the past two decades, Innerbody Research has helped tens of millions of readers make more informed decisions about staying healthy and living healthier lifestyles.
To help you navigate the alpha-lipoic acid supplement market, we dedicated over 160 hours to in-depth research. Our investigation started by examining ALA's role in human health, for which we reviewed several dozen research studies, scientific papers, and clinical trial results to understand its mechanisms, effective dosages, and potential benefits. With this foundational knowledge, we then thoroughly explored the current market, identifying and evaluating ALA products that align with the scientific literature on effectiveness and safety.
Additionally, like all health-related content on this website, this guide was thoroughly vetted by one or more members of our Medical Review Board for accuracy and will continue to be monitored for updates by our editorial team.
To identify the best alpha-lipoic acid supplements, we focused on the key factors that matter most to you. Our evaluation criteria included:
In the following sections, we explain how we chose the winner in each category:
Advantage: Double Wood Alpha Lipoic Acid
To evaluate effectiveness, we looked at how closely each product aligned with what’s worked in clinical trials. When we looked at effectiveness, a daily dose of 600mg of racemic ALA (a 50/50 mix of R- and S-isomers) stood out. Dozens of studies on conditions like diabetic neuropathy and metabolic dysfunction point to this as a common and effective amount.
Some studies suggest that doses of 1,200mg to 1,800mg daily might offer benefits, but these higher amounts also increase the risk of side effects. A key trial found that 600mg per day provided the best balance of effectiveness and tolerability, reducing instances of nausea, dizziness, and GI discomfort.4 A separate review of multiple studies supports this, concluding that 600mg daily is effective and well-tolerated for conditions like diabetic neuropathy, insulin resistance, and oxidative stress.5
That body of research has established 600mg of racemic ALA as a standard dose in clinical studies, thanks to its consistent balance of efficacy and tolerability. It’s high enough to deliver measurable benefits — and flexible enough to be used safely once, twice, or even three times daily under medical supervision.
Double Wood Alpha Lipoic Acid earns the top spot here because it:
Some products that use only R-ALA may offer advantages in absorption, but until more research confirms their performance at meaningful doses, the strongest case remains with what’s most tested: 600mg of racemic ALA per day.6
Insider Tip: It’s worth knowing that much of the research on ALA for nerve pain involved initial intravenous (IV) administration, followed by oral capsules. This might explain why some people don’t experience immediate results from oral supplements alone. Consistency and patience are key; daily use over time typically yields the best outcomes.
Advantage: Double Wood Alpha Lipoic Acid
All recommended products contain 600mg of racemic ALA or less — or a comparable amount of R-ALA — which falls within the dose range shown to be safe in long-term clinical use. One pivotal trial followed patients taking 600mg of racemic ALA daily for four years and found no significant safety concerns.7
We explore the differences between racemic ALA and R-ALA later in the guide, but it’s worth noting here: racemic ALA has the strongest long-term safety data in humans. That ultimately gave Double Wood the edge in this category — even though both it and Nootropics Depot impressed us with their transparency and third-party testing. Nootropics Depot uses a stabilized R-ALA formula, which may offer absorption advantages. However, stabilized R-ALA still lacks the volume of long-term clinical research supporting racemic ALA.
Every product we recommend in this guide meets basic safety standards: they are manufactured in GMP-certified facilities and have confirmed third-party testing to verify identity, potency, and purity.
Double Wood and Nootropics Depot stand out for safety due to exceptional transparency in testing and ingredient purity. Both companies undergo regular third-party testing and make their Certificates of Analysis (COAs) publicly available directly on their product pages — a level of transparency that's unfortunately rare in the supplement industry.
Safety highlights of some of the other companies include the following:
Advantage: Nutricost Alpha Lipoic Acid Capsules
If you’re just looking for the most budget-friendly way to add ALA to your routine, Nutricost Alpha Lipoic Acid is hard to beat. At just $0.10 per 300mg serving — or even $0.08 with subscription — it delivers 600mg of racemic ALA in a two-capsule serving for less than half the price of many competitors. It’s widely available on Amazon with Prime shipping and flexible multi-bottle discounts.
For those who want additional support for nerve health using more than just ALA, Bestvite’s combination of 300mg ALA and 150mg benfotiamine per capsule offers strong value. The price works out to just $0.32–$0.38 per 300mg serving, with free shipping on two or more bottles. A 2019 study found that this specific combination may relieve diabetic neuropathy symptoms more effectively than ALA alone — a promising low-cost solution for those focused on nerve pain management.8
Other options like Double Wood offer strong clinical alignment and quality, but cost more per capsule (around $0.33). For shoppers prioritizing value, Nutricost and Bestvite lead the field.
We’ve included a cost comparison table below to help you evaluate pricing across all products:
Price per 300mg Serving (One Time) | Price per 300mg Serving (Subscription) | Free Shipping | |
---|---|---|---|
Double Wood Alpha Lipoic Acid | $0.22 | $0.18 (20% off) | |
LongLifeNutri R-Alpha Lipoic Acid | $0.33 | N/A | No, $6 |
Nutricost Alpha Lipoic Acid | $0.10 (Amazon) | $0.08 (brand site, 20% off) | Free with Prime / $60+ brand site order |
Nootropics Depot R-ALA | $0.31 (3 caps) | N/A | |
Clean Nutraceuticals Nerve Defend | $ 0.50 (Amazon) | $0.43 (brand site, 15% off) | Free shipping with subscription (brand site) |
Bestvite Benfotiamine + ALA | $0.38 | $0.36 (5% off) | Free shipping on 2+ bottles |
Note: All prices are based on the brand’s website unless otherwise marked as “Amazon,” which offered a better value at the time of writing.
Advantage: Double Wood Alpha Lipoic Acid
When it comes to ease of use, Double Wood leads the pack. With a simple two-capsule daily dose, free shipping on all orders, and a generous first-bottle guarantee, it's a standout for users who want simplicity and strong customer support. Our research indicates that a 600mg daily serving will be best for most people, but you could easily take half that if you know you prefer a 300mg dose, effectively doubling Double Wood’s value.
That said, some other products shine when it comes to dose flexibility. Nootropics Depot’s 125mg R-ALA capsules give users more control over daily intake — a plus for those with sensitive digestion or personalized dosing needs.
We break down further details of these flexibility and convenience options in the following section.
The chart below offers a quick reference for comparing our top picks for ALA supplements — from potency and price to discounts, shipping, and more.
Alpha-lipoic acid (ALA) is a sulfur-containing compound that plays a central role in your body's energy metabolism and antioxidant defense systems.9 Your body produces some ALA naturally and also gets it from food. In the body, ALA performs three key roles in cellular health.
ALA helps protect your cells from damage caused by free radicals — unstable molecules linked to inflammation, aging, and chronic disease.10 Most antioxidants work in either water (like vitamin C) or fat (like vitamin E), but ALA is both water- and fat-soluble.9 That dual solubility allows it to protect a wider range of tissues throughout the body.
ALA helps regenerate other antioxidants like vitamins C and E, as well as glutathione. This recycling ability extends the lifespan of your body’s antioxidant defenses, enhancing ALA’s overall protective effect in cells. For this reason, ALA is also known as the “antioxidant of antioxidants.”9
Your body makes small amounts of ALA inside cells, where it stays bound to enzyme complexes and doesn’t circulate freely. That’s very different from what happens when you take ALA as a supplement.
Supplemental ALA enters your bloodstream in a free-floating form. This allows it to reach tissues that wouldn’t normally get much ALA — which may explain why higher supplemental doses (like 600mg) can affect nerve health, blood sugar, and oxidative stress in ways your body’s natural supply can’t.12
Once you take ALA as a supplement, several factors affect how well your body absorbs and uses it.
ALA is absorbed in the small intestine, with blood levels typically peaking 30 to 120 minutes after ingestion.13 To maximize absorption, experts typically recommend taking ALA supplements on an empty stomach.
To further understand how ALA supplements behave in the body, it helps to first know that not all ALA is the same.
Alpha-lipoic acid exists as two molecular mirror images, or isomers: R-ALA and S-ALA.
Most ALA supplements use a racemic mixture, which combines both R- and S-ALA in a 50:50 ratio. This approach is:
Some early research suggests R-ALA on its own may be more easily absorbed or better tolerated in sensitive individuals.17 18 Because R-ALA is more bioavailable, it spends less time in the stomach, moving more quickly into the intestines where absorption occurs. But because racemic ALA has a much longer track record in clinical trials — and because it offers greater manufacturing stability and affordability — it's often the more reliable and cost-effective choice for most users.
Outside of standard racemic ALA and purified R-ALA — which we’ve covered above — you’ll also find a few other supplement formats designed to enhance absorption, reduce side effects, or combine ingredients for synergistic effects:
These formulations gradually release ALA over several hours rather than all at once.62 Slower absorption may reduce gastrointestinal side effects like nausea or reflux and help maintain more stable blood levels throughout the day.
Some ALA supplements include added biotin as a precaution, based on limited evidence — primarily from animal studies — suggesting high doses of ALA might interfere with biotin metabolism.57 While the real-world significance in humans remains unclear, manufacturers include biotin to help prevent any potential deficiency.
R-ALA is the more bioactive form of alpha-lipoic acid, but it presents major stability challenges when isolated. This is one reason many supplements use racemic mixtures instead, which contain equal parts R- and S-ALA. Pure R-ALA degrades at room temperature, is sensitive to heat and light, and can polymerize — clumping into larger, inactive molecules — at temperatures above 115–120°F (46–49°C).42 These issues make it difficult to manufacture and store.
To address this, some companies use stabilized forms like Na-R-ALA (sodium-R-alpha-lipoate), which binds R-ALA to sodium to help resist degradation. Even so, these stabilized versions generally have shorter shelf lives and higher costs than racemic ALA.42
Liquid alpha-lipoic acid formulations can improve bioavailability compared to standard solid forms, likely due to faster uptake, potentially making them easier on digestion.54 61 However, liquid ALA requires a bit more care than capsules, like mandatory storage in a cool, dark place — ideally, the fridge.55
Liposomal ALA — alpha-lipoic acid encapsulated in a lipid membrane — is a newer delivery form designed to enhance bioavailability and protect ALA from degradation in the digestive tract. Early lab and animal studies suggest improved absorption and cellular uptake compared to standard ALA.58 However, human studies are limited, so its clinical superiority remains unproven.
ALA is often combined with other ingredients like benfotiamine, acetyl-L-carnitine (ALCAR), or N-acetylcysteine (NAC), particularly in products designed to support nerve health. By combining ALA with other ingredients that support nerve function, these formulas may offer more complete support than ALA on its own.
Most of what we know about ALA’s benefits comes from human clinical trials using doses of 300–1800mg daily for at least 3–12 weeks. While it’s not a cure-all, ALA may support nerve function, blood sugar regulation, and cellular defense against oxidative stress.
To help set the stage, the chart below outlines how different ALA dosages have been used in clinical research — and what kinds of results they’re associated with.
Typical Use in Research | Notes on Effectiveness & Safety | |
---|---|---|
300–600mg | Diabetic neuropathy, general antioxidant support | Most trials use 600mg of racemic ALA once daily. This dose has the best safety and efficacy data, especially for reducing nerve pain and improving insulin sensitivity.1 12 21 |
600–1200mg | Metabolic dysfunction, inflammation, oxidative stress | May enhance symptom relief for certain cardiometabolic markers. One study showed improvements in CRP and glucose control at doses ≥800mg/day over four years.36 |
1200–1800mg | Short-term use in more advanced cases of neuropathy or obesity | Some short-term studies show benefits at 1800mg a day, but long-term safety data is limited.37 Use above 1,200mg/day should be supervised by a healthcare provider. |
Many of ALA’s studied effects appear to be dose-dependent, with stronger responses seen at higher doses. However, side effects like nausea, dizziness, or gastrointestinal discomfort may also become more likely as the dose increases.
Keeping that in mind, the next chart summarizes what ALA might help with, based on the strength of human clinical evidence. We've ranked each use case as "Strong," "Moderate," or "Limited/Emerging" based on the quality and consistency of the data. A "Strong" rating indicates support from multiple well-designed trials, "Moderate" suggests promising but less consistent findings, and "Limited" or "Emerging" applies to areas with early-stage, small, or mixed research.
Evidence Strength | Notes | |
---|---|---|
Diabetic neuropathy relief | Strong | Clinical trials consistently show that 600mg/day of ALA can reduce nerve pain and tingling in people with diabetes. |
Blood sugar/insulin sensitivity | Moderate | ALA may slightly improve blood sugar and insulin response, though not enough to replace prescribed treatments. |
Cholesterol and lipid profile | Moderate | Meta-analyses report reductions in total cholesterol, LDL, and triglycerides — especially in those with diabetes or metabolic syndrome. HDL effects vary. |
Antioxidant/anti-inflammatory | Moderate | At doses over 800mg, ALA appears to lower C-reactive protein (CRP) and oxidative stress markers, but findings are mixed across trials. |
Weight loss | Weak to Moderate | ALA may promote mild weight loss, but the effect is small and unlikely to be clinically significant on its own. |
Brain/mitochondrial health | Emerging/Weak | Early findings suggest ALA might support brain and mitochondrial function, though current human research is limited. |
Skin health/anti-aging | Weak | Most evidence comes from animal or in vitro studies; clinical proof in humans remains sparse. |
Alpha-lipoic acid (ALA) is one of the most well-researched supplements for diabetic peripheral neuropathy, a common complication of diabetes that can lead to nerve pain, tingling, numbness, and weakness in the limbs.19 Several clinical trials, particularly those involving intravenous ALA, have shown that doses of 600mg per day can reduce these symptoms over a matter of weeks.20 21
ALA’s proposed benefit lies in its antioxidant activity. By reducing oxidative stress, ALA may help protect nerve cells from damage, improve nerve blood flow, and enhance overall nerve function.
While results from IV ALA studies are consistently positive, the picture is more mixed when it comes to oral-only supplementation:
Despite promising results from some trials, a recent systematic review evaluating eight randomized controlled trials indicates that findings on ALA's effectiveness in treating diabetic neuropathy symptoms are inconsistent.23 While ALA proved safe and tolerable across these studies, the review concluded that definitive evidence supporting significant benefits is limited. This suggests that individual responses to ALA supplementation can vary, and further research is needed to fully clarify its role in neuropathy management.
ALA’s role in cellular metabolism has led researchers to explore its potential effects on blood sugar control and insulin function. It acts as a coenzyme in the mitochondria — the “powerhouses” of the cell — where it helps convert glucose into ATP, the cell’s usable form of energy. This function may indirectly improve how cells respond to insulin.
Clinical studies and meta-analyses suggest that ALA supplementation can lead to small but meaningful improvements in fasting glucose and insulin sensitivity, particularly in people with type 2 diabetes or metabolic syndrome.2 24
That said, these effects are generally modest — and ALA should never be viewed as a substitute for prescribed diabetes medications. Instead, ALA may work best as a complementary therapy alongside standard treatments and lifestyle changes.
Alpha-lipoic acid (ALA) may help support a healthier lipid profile by reducing total cholesterol and triglyceride levels — especially in individuals with metabolic disorders like type 2 diabetes or metabolic syndrome.
Mechanistically, ALA may support lipid metabolism through several pathways:60
ALA works as an antioxidant by neutralizing reactive oxygen species (ROS) — unstable molecules that can damage liver cells and interfere with fat metabolism. By protecting these cells (called hepatocytes), ALA may help the liver process fats more efficiently, which could lead to healthier cholesterol and triglyceride levels.
Some research suggests ALA may reduce the activity of key enzymes involved in fat production, including HMG-CoA reductase — the same enzyme targeted by statin medications. By dialing down this enzyme and others involved in lipid storage, ALA could help lower cholesterol and reduce fat buildup in the body.
ALA supports the function of mitochondria — the parts of cells that generate energy. This support helps the body break down fatty acids more efficiently for energy, which can reduce the amount of fat stored in tissues or circulating as triglycerides in the blood.
However, it’s important to keep the following in mind:
ALA is best known for its antioxidant activity — and that’s not just in theory. It works in both water-soluble and fat-soluble environments, helping it protect a wide range of tissues from oxidative damage.25 It also regenerates other key antioxidants like glutathione, vitamin C, and vitamin E, reinforcing your body’s broader antioxidant network.12
Some animal studies, clinical trials, and meta-analyses suggest that ALA supplementation may help reduce oxidative stress and improve inflammatory markers like C-reactive protein (CRP).26 27 However, findings are mixed and more noticeable in people with elevated baseline inflammation.
Dosing appears to play a role — some trials have shown antioxidant effects with 800mg/day, while others suggest stronger responses at 1,200–2,400mg/day, particularly for lowering oxidative stress biomarkers in patients with multiple sclerosis.3 28 Keep in mind, though: while higher doses (typically 1,200–2,400mg per day) may offer stronger antioxidant effects, they also come with a greater chance of side effects like upset stomach or dizziness.
Research on ALA for weight loss shows modest effects in clinical trials — particularly for short-term reductions in body weight and BMI.
While results vary, ALA may offer minor support for weight management, particularly when paired with other lifestyle changes. However, ALA is not considered a standalone solution for weight management.
ALA plays a key role in supporting mitochondrial function — and since the brain is one of the body’s most energy-demanding organs, researchers have explored ALA’s potential neuroprotective effects. Preclinical studies suggest ALA may help defend neurons against oxidative stress, support synaptic function, and maintain healthy levels of glutathione, a critical antioxidant in brain cells.12 25
Importantly, ALA can cross the blood-brain barrier, making it a promising candidate for addressing conditions where oxidative stress or mitochondrial dysfunction play a role. However, evidence in healthy individuals is limited, and broad claims about cognitive enhancement aren’t well-supported by large human trials.
Still, some early clinical findings hint at potential uses in more specific contexts:
Research on ALA for skin health is limited, with most findings coming from in vitro and animal studies.33 34 These suggest that ALA’s antioxidant properties may help protect skin cells from UV damage, reduce inflammation, and support collagen integrity — all key factors in skin aging. However, there’s little human evidence confirming these effects from oral supplementation alone.
Topical ALA, on the other hand, shows some potential results. In a placebo-controlled clinical study, a 5% ALA cream delivered via a nanostructured lipid gel significantly reduced facial wrinkles and fine lines in adult volunteers after regular use. Participants also reported visible improvements in skin tone and texture, with no irritation or adverse effects.
The optimal ALA dosage varies based on your specific health goals. Clinical research supports a range of 300–1,800mg per day. Among these, 600mg of racemic ALA taken once daily is the most common and well-tolerated therapeutic dose, particularly for conditions like diabetic neuropathy.
Here’s how typical doses compare:
Doses in this range have been studied for their potential to address metabolic dysfunction, inflammation, and oxidative stress. One long-term trial found that taking 800mg daily for four years improved CRP levels and glucose control.36
Higher doses in this range have been explored in short-term studies, particularly for more advanced cases of neuropathy or obesity. Some studies report benefits at 1,800mg per day, but long-term safety data at these levels are limited.37
Alpha-lipoic acid (ALA) is generally considered safe for most adults when it's used at standard doses of 300-600mg per day. Long-term clinical trials, including one that lasted four years, found no serious safety concerns at these levels.7
Most people tolerate ALA well, but some mild side effects can occur, especially at higher doses:
These side effects are usually temporary and mild, but they appear more frequently at doses of 1,200mg/day or higher.3 4
ALA may interact with several medications and should be used with caution in these cases:39
ALA can help lower blood glucose, which may enhance the effects of diabetes drugs and increase the risk of hypoglycemia. If you’re taking medications for blood sugar control, consult your doctor and monitor levels closely.
Some evidence suggests that ALA may interfere with thyroid hormone activity, potentially reducing the effectiveness of these medications when taken together.
Due to its antioxidant properties, ALA may interfere with the efficacy of certain chemotherapy agents, including alkylating agents and antitumor antibiotics. If you’re undergoing cancer treatment, talk to your oncologist before starting ALA.
Small clinical studies suggest that ALA may be safe during pregnancy at doses up to 600mg/day for several weeks, with no serious adverse effects reported.40 However, larger, long-term studies are lacking, and there is no reliable safety data for breastfeeding. Most medical sources recommend avoiding ALA during pregnancy or lactation unless advised otherwise by a healthcare provider.
While trials have tested up to 1200mg/day (even as high as 2400mg/day) and illustrated safety, some report higher rates of gastrointestinal side effects, dizziness, and skin reactions at these levels.14 28 38 Additionally, these higher doses are often short-term (3–5 weeks) and used under clinical supervision.
Multiple trials suggest that 600–1,200mg/day of ALA is well tolerated over extended periods. A four-year study in individuals with metabolic disorders found no significant increase in adverse events with higher doses compared to lower ones.36
Alpha-lipoic acid isn’t for everyone, but certain people stand to benefit more than others.
ALA may be helpful for:
However, ALA may not be appropriate if:
Your body naturally produces some ALA, and small amounts are found in foods like spinach, broccoli, red meat, and organ meats.41 In healthy individuals, taking an ALA supplement may offer little to no added benefit.
These claims are common in marketing, but human evidence remains limited. Most of the research in these areas comes from in vitro or animal studies, and there are no high-quality clinical trials consistently showing cosmetic or lifespan-extending effects in people.33 34 66 A few small studies suggest topical ALA may offer modest benefits for skin appearance, but these findings are early and so far don’t apply to oral supplementation.35
ALA can interact with several medications.39 These include drugs for diabetes (like insulin or metformin), thyroid medications (like levothyroxine), and certain chemotherapy agents such as alkylating agents and antitumor antibiotics. Before adding ALA to your supplement regimen, talk to your doctor to make sure it’s safe and appropriate for your situation.
Best overall
Photo by Innerbody Research
Founded in 2013 and based in Pennsylvania, Double Wood Supplements manufactures its products in the U.S. at cGMP-certified facilities. Most of its supplements include third-party test results and Certificates of Analysis (COAs) directly on the product pages — a level of transparency that’s still relatively uncommon in the supplement industry.
Double Wood’s alpha-lipoic acid supplement delivers a full 600 mg of encapsulated, racemic ALA per serving — the same form and dose used in many of the most robust clinical studies supporting ALA’s role in diabetic neuropathy, metabolic health, and antioxidant support.1 4 36 This format offers the best balance of clinical validation and affordability, especially for those seeking a therapeutic dose. The capsules are vegan-friendly and made with minimal, well-tolerated ingredients, free from common allergens and unnecessary fillers.
Here’s a quick breakdown of pricing options. All orders come with free shipping directly from the brand site:
Double Wood offers a money-back guarantee on your first bottle — even for bulk orders, so long as unopened bottles are returned. That means you get to keep the first bottle on them.
Customer service was also a standout: they responded to our COA request in under an hour, faster than any other company we contacted during this review.
Best R-lipoic acid supplement (for enhanced absorption)
Photo by Innerbody Research
LongLifeNutri delivers 300mg of sodium-stabilized R-alpha-lipoic acid (Na-R-ALA) per capsule — a form of ALA that’s often marketed for superior absorption and bioactivity compared to standard alpha-lipoic acid. Most ALA supplements contain a racemic mixture, meaning they include both the R- and S- forms of alpha-lipoic acid in equal amounts. But only the R-isomer (R-ALA) is naturally produced in the body and actively participates in mitochondrial energy metabolism.12
Some studies suggest that R-ALA may be more bioavailable than standard racemic ALA — though the clinical significance of this difference is still under investigation.17 In addition, anecdotal reports and small studies indicate that R-ALA may be easier on digestion, with fewer gastrointestinal side effects than standard racemic ALA, especially at higher doses.18
However, R-ALA is chemically unstable on its own. To improve shelf life and prevent degradation, LongLifeNutri uses a sodium-stabilized form (Na-R-ALA), which enhances the product’s structural integrity and ensures more consistent potency.42 However, Na-R-ALA may still lose potency during storage, especially under conditions of heat or humidity.
Taken together, the evidence supports using racemic ALA — which is why it forms the basis of our top recommendation.
At $39.90 for 120 capsules, LongLifeNutri’s R-ALA costs about $0.33 per capsule — the same per-capsule price as Double Wood’s racemic ALA at the one-time purchase rate. That makes it a strong value for an R-ALA supplement, especially given its use of the stabilized Na-R-ALA form, which typically carries a higher price tag.
However, unlike Double Wood, LongLifeNutri doesn’t offer a subscription option or free shipping. A $6 shipping fee brings the effective price to about $0.38 per capsule. The product is also available on Amazon with free Prime shipping, but it’s currently listed at $49.90 — about $0.42 per capsule.
Overall, while R-ALA supplements usually cost more than standard racemic options, LongLifeNutri delivers solid per-milligram value — particularly for shoppers looking for a stabilized R-ALA without the premium-brand markup.
LongLifeNutri offers a 365-day satisfaction guarantee, which is unusual in the supplement industry. Returns and refunds are honored even on opened products.
Additionally, customer service was prompt in our request for a COA (provided by email).
Best budget-friendly ALA
Photo by Innerbody Research
Nutricost provides one of the most affordable ways to supplement with alpha-lipoic acid at clinically relevant doses. Each serving delivers 600mg of racemic ALA — the same form and dose used in many studies on diabetic neuropathy, oxidative stress, and metabolic support.1 22 36
The two-capsule format makes it easy to divide the 600mg daily dose into two 300mg servings taken with meals — a strategy supported by clinical research. Splitting ALA into smaller doses may help reduce gastrointestinal side effects, especially at higher intakes.43 Taking ALA with food can also improve tolerability — though some studies suggest it may slightly reduce absorption.13 44 That tradeoff may be worth it for users sensitive to GI effects, particularly when taking ALA long-term.
Nutricost manufactures its supplements in GMP-compliant facilities and subjects them to third-party testing through ISO-accredited labs. COAs are available upon request when you provide a batch or lot number.
Nutricost’s value stands out. On Amazon, you can get 240 capsules (120 servings) for $24.89 — just $0.21 per serving — making it the most affordable ALA option from our recommendations. A 2-bottle bundle on Nutricost’s official site (also 240 capsules total) costs $64.25 with free shipping, which is notably less competitive.
A Subscribe & Save option is available both on Amazon and Nutricost’s website. However, on Nutricost.com, subscriptions are only in 30-day intervals, making the 60-capsule bottle the only practical option. Even with the 20% discount ($10.38), this price doesn’t meet the site’s $59 minimum for free shipping. Standard shipping adds around $5 depending on your location, which diminishes the overall savings.
Given these factors, most users will find the best value and convenience by ordering Nutricost ALA through Amazon — though it does mean relying on Amazon’s return policy instead of Nutricost’s own 60-day guarantee.
Nutricost offers a 60-day satisfaction guarantee on all orders. While the product must be returned, the policy is clearly outlined. Customer support is accessible through the Nutricost website and was responsive to our inquiries about a certificate of analysis (COA), which is available upon request with a lot number.
Best low-dose R-ALA (for flexible, GI-friendly dosing)
Photo by Innerbody Research
Nootropics Depot’s low-dose R-alpha-lipoic acid supplement is a standout for quality and transparency. Each capsule delivers 125mg of sodium-stabilized R-ALA (Na-R-ALA) — a form that helps prevent the degradation issues associated with unbound R-ALA. This added stability gives it an edge over standard R-ALA supplements, especially for users concerned about shelf life or inconsistent potency.
The 125mg dose is ideal for gradual titration across meals, which may help minimize the gastrointestinal side effects sometimes associated with ALA — like nausea or reflux.18 43 Taking three capsules daily (375mg R-ALA) equates to just above the 600mg dose of racemic ALA used in many clinical trials.17
A single 60-count bottle costs $24.99, but shipping adds about $10 unless you buy in bulk. At 180 capsules for $54.99, you qualify for free shipping, bringing the per-capsule cost to about $0.31 either way. However, as we stated above, you’ll need about three caps. This makes Nootropics Depot one of the most expensive options from our list of recommendations.
Still, while not the cheapest option on the market, the flexible dosing, stabilized format, and third-party testing justify the higher price.
Nootropics Depot accepts returns of unopened products within 30 days of delivery. It’s not the most generous policy — and there’s no satisfaction guarantee — but it’s common among supplement brands. Fortunately, all third-party testing and manufacturing certifications are clearly posted on their site, helping inspire confidence before you buy.
Best complex ALA formula for nerve health
Clean Nutraceuticals Nerve Defend is one of the most comprehensive nerve support formulas available. Each 3-capsule daily serving delivers 600 mg of alpha-lipoic acid, 300 mg of benfotiamine, 600 mg of N-acetylcysteine (NAC), and 500 mg of acetyl-L-carnitine (ALCAR) — four ingredients commonly studied for their role in reducing neuropathic pain and improving nerve function.
ALA is the central ingredient in this formula, and out of everything included with Nerve Defend, has the most clinical evidence supporting its use for diabetic neuropathy. It works as a potent antioxidant, improves blood flow to nerves, and enhances glucose uptake — all of which can help reduce burning, tingling, and pain associated with neuropathy.1
Clinical trials have shown consistent benefits at 600mg per day, particularly when taken long-term and under medical supervision.7
Benfotiamine is a fat-soluble form of vitamin B1 (thiamine) with significantly better bioavailability than standard thiamine.46 It plays a central role in glucose metabolism and helps prevent the accumulation of harmful byproducts like advanced glycation end products (AGEs), which contribute to nerve damage in diabetes.
When combined with alpha-lipoic acid, some early research has shown that benfotiamine may enhance effects in reducing pain and improving nerve conduction in people with diabetic neuropathy.8 The synergy likely stems from their complementary mechanisms: benfotiamine helps manage glucose-induced damage, while ALA reduces oxidative stress and improves blood flow.
ALCAR is a mitochondrial cofactor that plays a key role in cellular energy production and nerve cell maintenance.48 It’s been shown to improve nerve regeneration and reduce neuropathic pain in people with diabetes, particularly at daily doses of 1,000–2,000mg.49 While Nerve Defend provides a lower dose, combining ALCAR with ALA and NAC may enhance its therapeutic effect.63 64
NAC is a precursor to glutathione — one of the body’s most important antioxidants.50 In the context of diabetic neuropathy, oxidative stress plays a major role in nerve damage. By replenishing glutathione stores, NAC helps protect neurons and may reduce inflammation and pain.
Clinical studies have used doses around 1,200mg per day, but even lower doses may offer benefit, especially when combined with other antioxidants like ALA.51
The one major drawback of Nerve Defend is its low B12 content. While the formula includes vitamin B12 (as methylcobalamin), the amount is only 100 mcg per serving — far below the 500–1,000mcg daily doses used in clinical studies showing benefit for diabetic neuropathy.52
Clean Nutraceuticals offers Nerve Defend for $29.95 (30 servings). At about $1 per day, it’s among the most cost-effective neuropathy blends, especially for what it consolidates.
You can subscribe to Nerve Defend directly from their website and save 15% off. If you buy five bottles every five months, you can bring down the daily cost to about $.0.85 for two caps.
The brand offers a standard satisfaction guarantee, and customer support confirmed that a certificate of analysis (COA) is available upon request.
Best budget complex ALA formula for nerve health
Photo by Innerbody Research
Bestvite’s budget-friendly formula delivers a time-tested pairing of alpha-lipoic acid (ALA) and benfotiamine — two compounds with distinct but complementary mechanisms for supporting nerve health. Each capsule contains 300mg of ALA and 150mg of benfotiamine, and the recommended two-capsule daily dose mirrors what’s used in many diabetic neuropathy trials.
ALA is widely recognized for its ability to reduce oxidative stress, improve microcirculation, and relieve symptoms of diabetic neuropathy, including burning, tingling, and pain.17 Benfotiamine, a fat-soluble derivative of vitamin B1 (thiamine), helps reduce the formation of advanced glycation end products (AGEs), which are major contributors to nerve damage in diabetes.46
Some research shows that combining ALA with benfotiamine can result in greater symptom improvement than using either compound alone.47 And while benfotiamine alone has produced mixed results, it’s well-tolerated and is potentially more effective when stacked with ALA.53
A single bottle (120 capsules) costs $22.94, including $3.95 shipping, and lasts 60 days at the standard two-capsule dose. Buying two bottles drops the per-bottle price to $18.99 with free shipping, lowering the cost per serving to about $0.32 — one of the lowest of any nerve-support stack we reviewed.
Bestvite also offers a Subscribe & Save program with 5% off. Importantly, you can customize the frequency of your subscription (e.g., receive two bottles every four months), allowing you to stay stocked while hitting the free shipping threshold. It’s not the steepest discount on the market, but combined with bulk pricing, it still delivers excellent value.
Bestvite offers a 60-day return window, but only on unopened products. While the policy isn’t as flexible as Double Wood’s or LongLifeNutri’s, it’s a reasonable tradeoff given the price. The brand also has a rewards program for repeat buyers.
Whether you’re sensitive to ALA or simply exploring additional ways to support nerve health or manage oxidative stress, several other options exist. While ALA is well-researched and widely used, it’s not the only tool available. In many cases, these alternatives can also be used alongside ALA for broader support.
You can get small amounts of ALA through food, and nutrients like vitamin B12 and acetyl-L-carnitine (ALCAR) have shown promise in human studies, particularly for diabetic neuropathy.
Whatever your reason for exploring alternatives, the following options are among the most worthwhile to consider.
While ALA supplements provide concentrated doses, certain foods naturally contain ALA, albeit in smaller amounts.54 Incorporating these into your diet can support overall antioxidant intake:
It’s worth noting that lipoic acid from food has not been shown to significantly raise free lipoic acid levels in human plasma or cells, making it unlikely that therapeutic effects can be achieved through diet alone.14 However, if you’re a healthy individual, a diet rich in whole foods should be all you need for proper ALA intake.
If you’re exploring options beyond alpha-lipoic acid for nerve health or oxidative stress, two of the most studied and promising alternatives are vitamin B12 and acetyl-L-carnitine (ALCAR).56 Each plays a unique role in nerve protection and repair, particularly in the context of diabetic neuropathy.
Vitamin B12 is essential for red blood cell formation, DNA synthesis, and the maintenance of healthy nerve cells. Deficiencies in B12 can directly lead to nerve damage and worsen symptoms of diabetic neuropathy.65 While most people can get adequate B12 through diet (meat, fish, dairy, fortified cereals), certain medications — including metformin and proton pump inhibitors — can impair absorption and raise the risk of deficiency.
Clinical studies suggest that daily doses of 500–1,000mcg of methylcobalamin (the active form of B12) may reduce neuropathic pain and improve nerve conduction — especially in those who are B12 deficient.52 Vitamin B12 is generally safe and well-tolerated when taken as directed, and it can often be used alongside ALA.8
ALCAR is a compound naturally produced by the liver and kidneys that helps shuttle fatty acids into mitochondria to be converted into energy. It also supports nerve regeneration and reduces oxidative stress — two mechanisms thought to underlie its benefits for diabetic neuropathy.48
Randomized trials have shown that taking 1,000–2,000mg of ALCAR daily may help reduce pain, improve vibration perception, and enhance nerve conduction in people with diabetic neuropathy — especially when treatment begins early.49 Vibration perception refers to the ability to sense low-frequency vibrations, such as those from tuning forks — a key part of nerve function often tested in clinical exams to assess sensory loss in the feet and legs.
These benefits may complement ALA’s antioxidant and nerve-supporting effects, making ALCAR a potential co-therapy for those looking to take a multi-pronged approach.63
ALCAR is generally well tolerated, though side effects like agitation, dry mouth, or insomnia may occur in sensitive individuals. ALCAR may also interact with medications such as warfarin or thyroid hormone, so consultation with a healthcare provider is advised.
Sources
Innerbody uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
Mijnhout, G. S., Kollen, B. J., Alkhalaf, A., Bravenboer, B., Feskens, E. J. M., & Bilo, H. J. G. (2012). Alpha Lipoic Acid for Symptomatic Peripheral Neuropathy in Patients with Diabetes: A Meta-Analysis of Randomized Controlled Trials. Diabetic Medicine, 29(12), 1475-1481.
Akbari, M., Larijani, B., & Sohrab, G. (2018). The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials. Journal of Diabetes & Metabolic Disorders, 17(1), 153-162.
Jian, Z., Luo, T., Zheng, L., Wei, F., & Li, R. (2021). Effect of alpha-lipoic acid on oxidative stress parameters: A systematic review and meta-analysis. Journal of Clinical Pharmacy and Therapeutics, 46(5), 1184-1191.
Ziegler, D., Ametov, A., Barinov, A., Dyck, P. J., Gurieva, I., Low, P. A., Novikova, L., & Schütte, K. (2006). Oral treatment with α-lipoic acid improves symptomatic diabetic polyneuropathy: The SYDNEY 2 trial. Diabetes Care, 29(11), 2365–2370.
Ziegler, D., & Gries, F. A. (2004). Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review. Treatments in Endocrinology, 3(3), 173-189.
Hermann, R., Niebch, G., Borbe, H. O., Fieger-Büschges, H., Ruus, P., Nowak, H., Riethmüller-Winzen, H., Peukert, M., & Blume, H. (1996). Enantioselective pharmacokinetics and bioavailability of different racemic α-lipoic acid formulations in healthy volunteers. European Journal of Pharmaceutical Sciences, 4(3), 167–174.
Ziegler, D., Low, P. A., Litchy, W. J., Boulton, A. J. M., Vinik, A. I., Freeman, R., Samigullin, R., Tritschler, H., Munzel, U., Maus, J., Schütte, K., & Dyck, P. J. (2011). Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: The NATHAN 1 trial. Diabetes Care, 34(9), 2054–2060.
Popa, A. R., Bungau, S., Vesa, C. M., Bondar, A. C., Pantis, C., Maghiar, O., Dimulescu (Nica), I. A., Cseppento, D. C. N., & Rus, M. (2019). Evaluating the efficacy of the treatment with benfotiamine and alpha-lipoic acid in distal symmetric painful diabetic polyneuropathy. Revista de Chimie, 70(9), 3108–3114.
Superti, F., & Russo, R. (2024). Alpha-Lipoic Acid: Biological Mechanisms and Health Benefits. Antioxidants (Basel), 13(10), 1228.
Yang, J., Luo, J., Tian, X., Zhao, Y., Li, Y., & Wu, X. (2024). Progress in Understanding Oxidative Stress, Aging, and Aging-Related Diseases. Antioxidants, 13(4), 394.
Hagen, T. M., Moreau, R., Suh, J. H., & Visioli, F. (2011). Lipoic acid: energy metabolism and redox regulation of transcription and cell signaling. Journal of Clinical Biochemistry and Nutrition, 48(1), 26-32.
Shay, K. P., Moreau, R. F., Smith, E. J., Smith, A. R., & Hagen, T. M. (2009). Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential. Biochimica et Biophysica Acta (BBA) - General Subjects, 1790(10), 1149–1160.
Gleiter, C. H., Schug, B. S., Hermann, R., Elze, M., Blume, H. H., & Gundert-Remy, U. (1996). Influence of food intake on the bioavailability of thioctic acid enantiomers. European Journal of Clinical Pharmacology, 50(6), 513–514.
Linus Pauling Institute. (2019). Lipoic acid. Micronutrient Information Center, Oregon State University.
Hsieh, R. Y., Huang, I. C., Tsai, H. H., & Kuo, M. L. (2023). Effects of Oral Alpha-Lipoic Acid Treatment on Diabetic Polyneuropathy: A Meta-Analysis and Systematic Review. Nutrients, 15(16), 3634.
Mansoori, A., Poorebrahimi, S., Qorbani, M., & Hekmatdoost, A. (2019). Alpha-lipoic acid (ALA) supplementation effect on glycemic and inflammatory biomarkers: A Systematic Review and meta-analysis. Clinical Nutrition ESPEN, 32, 78–86.
Yoon, J., Moon, S. J., Lee, K. O., Yoon, S. H., Jang, I. J., Yu, K. S., & Lee, S. H. (2016). Comparison of R(+)-α-lipoic acid exposure after R(+)-α-lipoic acid 200 mg and 300 mg and thioctic acid 600 mg in healthy Korean male subjects. Translational and Clinical Pharmacology, 24, 137–142.
Cameron, M., Taylor, C., Lapidus, J., Ramsey, K., Koop, D., & Spain, R. (2020). Gastrointestinal tolerability and absorption of R- versus R,S-lipoic acid in progressive multiple sclerosis: A randomized crossover trial. The Journal of Clinical Pharmacology, 60(11), 1511–1519.
Obrosova, I. G. (2009). Diabetes and the peripheral nerve. Biochimica et Biophysica Acta, 1792(10), 931–940.
Ziegler, D., Hanefeld, M., Ruhnau, K. J., Meissner, H. P., Lobisch, M., Schütte, K., & Gries, F. A. (1995). Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid: A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia, 38(12), 1425–1433.
Ziegler, D., Nowak, H., Kempler, P., Vargha, P., & Low, P. A. (2004). Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabetic Medicine, 21(2), 114–121.
Gomes, M. B., & Negrato, C. A. (2014). Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases. Diabetology & Metabolic Syndrome, 6, Article 80.
Abdullahi, A., El-Fakharany, A., El-Sayed, O., & Abdel-Rahman, R. S. (2022). Effectiveness of α-lipoic acid in the treatment of diabetic neuropathy: A systematic review. Journal of Taibah University Medical Sciences, 17(5), 785–790.
Kamenova, P. (2006). Improvement of insulin sensitivity in patients with type 2 diabetes mellitus after oral administration of alpha-lipoic acid. Hormones (Athens), 5(4), 251–258.
Packer, L., Witt, E. H., & Tritschler, H. J. (1995). alpha-Lipoic acid as a biological antioxidant. Free Radical Biology and Medicine, 19(2), 227–250.
Fayez, A. M., Zakaria, S., & Moustafa, D. (2018). Alpha lipoic acid exerts antioxidant effect via Nrf2/HO-1 pathway activation and suppresses hepatic stellate cells activation induced by methotrexate in rats. Biomedicine & Pharmacotherapy, 105, 428–433.
Saboori, S., Falahi, E., Eslampour, E., Zeinali Khosroshahi, M., & Yousefi Rad, E. (2018). Effects of alpha-lipoic acid supplementation on C-reactive protein level: A systematic review and meta-analysis of randomized controlled clinical trials. Nutrition, Metabolism and Cardiovascular Diseases, 28(8), 779–786.
Yadav, V., Marracci, G., Lovera, J., Woodward, W., Bogardus, K., Marquardt, W., Shinto, L., Morris, C., & Bourdette, D. (2005). Lipoic acid in multiple sclerosis: a pilot study. Multiple Sclerosis Journal, 11(3), 329–335.
Kucukgoncu, S., Zhou, E., Lucas, K. B., & Tek, C. (2017). Alpha-Lipoic Acid (ALA) as a supplementation for weight loss: Results from a Meta-Analysis of Randomized Controlled Trials. Obesity Reviews, 18(5), 594–601.
Vajdi, M., & Farhangi, M. A. (2020). Alpha-lipoic acid supplementation significantly reduces the risk of obesity in an updated systematic review and dose response meta-analysis of randomised placebo-controlled clinical trials. International Journal of Clinical Practice, 74(6), e13493.
Gao, K., Wu, Y., Zhang, Y., Dang, P., Xue, H., Li, T., Zhou, M., Wang, L., & Zhu, Y. (2025). Alpha-lipoic acid alleviates oxidative stress and brain damage in patients with sevoflurane anesthesia. Frontiers in Pharmacology, 16, 1572156.
Spain, R., Powers, K., Murchison, C., Heriza, E., Winges, K., Yadav, V., Cameron, M., Kim, E., Horak, F., Simon, J., & Bourdette, D. (2017). Lipoic acid in secondary progressive MS: A randomized controlled pilot trial. Neurology: Neuroimmunology & Neuroinflammation, 4(5), e374.
de Bengy, A.-F., Decorps, J., Martin, L. S., Pagnon, A., Chevalier, F. P., Sigaudo-Roussel, D., & Fromy, B. (2022). Alpha-Lipoic Acid Supplementation Restores Early Age-Related Sensory and Endothelial Dysfunction in the Skin. Biomedicines, 10(11), 2887.
Badran, M., Abuyassin, B., Golbidi, S., Ayas, N., & Laher, I. (2019). Alpha Lipoic Acid Improves Endothelial Function and Oxidative Stress in Mice Exposed to Chronic Intermittent Hypoxia. Oxidative Medicine and Cellular Longevity, 2019, 4093018.
Sherif, S., Bendas, E. R., & Badawy, S. (2014). The clinical efficacy of cosmeceutical application of liquid crystalline nanostructured dispersions of alpha lipoic acid as anti-wrinkle. European Journal of Pharmaceutics and Biopharmaceutics, 86(2), 251–259.
Derosa, G., D'Angelo, A., Preti, P., & Maffioli, P. (2020). Safety and Efficacy of Alpha Lipoic Acid During 4 Years of Observation: A Retrospective, Clinical Trial in Healthy Subjects in Primary Prevention. Drug Design, Development and Therapy, 14, 5367–5374.
Koh, E. H., Lee, W. J., Lee, S. A., Kim, E. H., Cho, E. H., Jeong, E., Kim, D. W., Kim, M.-S., Park, J.-Y., Park, K.-G., Lee, H.-J., Lee, I.-K., Lim, S., Jang, H. C., Lee, K. H., & Lee, K.-U. (2011). Effects of alpha-lipoic Acid on body weight in obese subjects. The American Journal of Medicine, 124(1), 85.e1-85.e8.
StatPearls Publishing. (2023, November 6). Alpha Lipoic Acid. In StatPearls. National Center for Biotechnology Information (NCBI).
MedlinePlus. (n.d.). Alpha-lipoic acid. National Library of Medicine. Retrieved May 28, 2025, from
Parente, E., Colannino, G., Picconi, O., & Monastra, G. (2017). Safety of oral alpha-lipoic acid treatment in pregnant women: a retrospective observational study. European Review for Medical and Pharmacological Sciences, 21(18), 4219–4227.
Mount Sinai. (n.d.). Alpha-lipoic acid.
Ikuta, N., Sugiyama, H., Shimosegawa, H., Nakane, R., Ishida, Y., Uekaji, Y., Nakata, D., Pallauf, K., Rimbach, G., Terao, K., & Matsugo, S. (2013). Analysis of the Enhanced Stability of R(+)-Alpha Lipoic Acid by the Complex Formation with Cyclodextrins. International Journal of Molecular Sciences, 14(2), 3639–3655.
McIlduff, C. E., & Rutkove, S. B. (2011). Critical appraisal of the use of alpha lipoic acid (thioctic acid) in the treatment of symptomatic diabetic polyneuropathy. Therapeutics and Clinical Risk Management, 7, 377–385.
Sarezky, D., Raquib, A. R., Dunaief, J. L., & Kim, B. J. (2016). Tolerability in the elderly population of high-dose alpha lipoic acid: a potential antioxidant therapy for the eye. Clinical Ophthalmology, 10, 1899–1903.
Haupt, E., Ledermann, H., & Köpcke, W. (2005). Benfotiamine in the treatment of diabetic polyneuropathy—a three-week randomized, controlled pilot study (BEDIP study). International Journal of Clinical Pharmacology and Therapeutics, 43(2), 71–77.
Bozic, I., & Lavrnja, I. (2023). Thiamine and benfotiamine: Focus on their therapeutic potential. Heliyon, 9(11), e21839.
Čolak, E., Kozić, D., Jović, J., Ristić, G., & Kovačević, L. (2017). Neurophysiological evaluation of short-term outcome of pharmacological treatment of diabetic neuropathy. Vojnosanitetski pregled, 74(8), 723–727.
NIH Office of Dietary Supplements. (2023). Carnitine - Health Professional Fact Sheet. NIH Office of Dietary Supplements.
Di Stefano, G., Di Lionardo, A., Galosi, E., Truini, A., & Cruccu, G. (2019). Acetyl-L-carnitine in painful peripheral neuropathy: a systematic review. Journal of Pain Research, 12, 1341–1351.
Ershad, M., Naji, A., Patel, P., & Vearrier, D. (2024). N-Acetylcysteine. In StatPearls. StatPearls Publishing.
Heidari, N., Sajedi, F., Mohammadi, Y., Mirjalili, M., & Mehrpooya, M. (2019). Ameliorative Effects Of N-Acetylcysteine As Adjunct Therapy On Symptoms Of Painful Diabetic Neuropathy. Journal of Pain Research, 12, 3147–3159.
Didangelos, T., Karlafti, E., Kotzakioulafi, E., Margariti, E., Giannoulaki, P., Batanis, G., Tesfaye, S., & Kantartzis, K. (2021). Vitamin B12 Supplementation in Diabetic Neuropathy: A 1-Year, Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients, 13(2), 395.
Fraser, D. A., Diep, L. M., Hovden, I. A., Nilsen, K. B., Sveen, K. A., Seljeflot, I., & Hanssen, K. F. (2012). The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-month, double-blind, randomized, placebo-controlled trial. Diabetes Care, 35(5), 1095–1097.
Salehi, B., Yılmaz, Y. B., Antika, G., Tumer, T. B., Mahomoodally, M. F., Lobine, D., Akram, M., Riaz, M., Capanoglu, E., Sharopov, F., Martins, N., Cho, W. C., & Sharifi-Rad, J. (2019). Insights on the Use of α-Lipoic Acid for Therapeutic Purposes. Biomolecules, 9(8), 356.
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Turck, D., Castenmiller, J., de Henauw, S., Hirsch-Ernst, K. I., Kearney, J., Knutsen, H. K., Mangelsdorf, I., McArdle, H. J., Naska, A., Pelaez, C., Pentieva, K., Siani, A., Thies, F., Tsabouri, S., Vinceti, M., Cappellani, D., Ijzerman, R., Van Loveren, H., Titz, A., & Maciuk, A. (2021). Scientific opinion on the relationship between intake of alpha-lipoic acid (thioctic acid) and the risk of insulin autoimmune syndrome. EFSA Journal, 19(6), e06577.
Mayo Clinic. (2024). Diabetic neuropathy: Can dietary supplements help?. Mayo Clinic.
Zempleni, J., Trusty, T. A., & Mock, D. M. (1997). Lipoic Acid Reduces the Activities of Biotin-Dependent Carboxylases in Rat Liver. The Journal of Nutrition, 127(9), 1776–1781.
Bellini, C., Mancin, F., Papini, E., & Tavano, R. (2024). Nanotechnological Approaches to Enhance the Potential of α-Lipoic Acid for Application in the Clinic. Antioxidants (Basel), 13(6), 706.
Ahmadi, M., Keshavarz, S. A., & Abbasi, B. (2022). Effects of alpha lipoic acid supplementation on serum lipid profile in patients with metabolic syndrome: A randomized, double-blind, placebo-controlled clinical trial. ARYA Atherosclerosis Journal, 18(4), 1–8.
Mousavi, S. M., Shab-Bidar, S., Kord-Varkaneh, H., Khorshidi, M., & Djafarian, K. (2019). Effect of alpha-lipoic acid supplementation on lipid profile: A systematic review and meta-analysis of controlled clinical trials. Nutrition, 59, 121–130.
Brufani, M., & Figliola, R. (2014). (R)-α-lipoic acid oral liquid formulation: pharmacokinetic parameters and therapeutic efficacy. Acta Bio-Medica, 85(2), 108–115.
Zaky, A. A., & Zaki, M. A. (2023). Recent developments in encapsulation of α-lipoic acid for enhanced bioavailability and stability. Quality Assurance and Safety of Crops & Foods, 15(1), 123–138.
Lopez-Maldonado, A., Pastoriza, S., & Rufián-Henares, J. Á. (2021). Assessing the antioxidant and metabolic effect of an alpha-lipoic acid and acetyl-L-carnitine nutraceutical. Current Research in Food Science, 4, 336–344.
Karalija, A., Novikova, L. N., Kingham, P. J., Wiberg, M., & Novikov, L. N. (2012). Neuroprotective effects of N-acetyl-cysteine and acetyl-L-carnitine after spinal cord injury in adult rats. PLoS ONE, 7(7), e41086.
Schleicher, E., Didangelos, T., Kotzakioulafi, E., Cegan, A., Peter, A., & Kantartzis, K. (2023). Clinical pathobiochemistry of vitamin B12 deficiency: Improving our understanding by exploring novel mechanisms with a focus on diabetic neuropathy. Nutrients, 15(11), 2597.
Farr, S. A., Price, T. O., Banks, W. A., Ercal, N., & Morley, J. E. (2012). Effect of alpha-lipoic acid on memory, oxidation, and lifespan in SAMP8 mice. Journal of Alzheimer’s Disease, 32(2), 447–455. https://doi.org/10.3233/JAD-2012-120130